Layered Polymer Coatings for Alcohol-Resistant Drug Formulations
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing modified release oral dosage forms are vulnerable to alcohol-induced dose dumping, posing safety risks and diminished efficacy, particularly for drugs like GHB, paracetamol, and opioids, which can cause serious side effects when large amounts are released rapidly.
Innovation Solution
Coating drug-containing cores with a specific polymer blend of cellulose and polymethacrylates, such as ethyl cellulose and polymethacrylate, to resist alcohol-induced dose dumping, maintaining controlled drug release even in the presence of increasing alcohol concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If modified release oral dosage forms use typical release-rate-controlling mechanisms (swellable polymers, gel matrixes, polymeric coatings), then drug release is controlled under normal conditions, but alcohol-induced dose dumping occurs when alcohol is co-ingested
Solution Approach 1:
The patent applies composite materials by combining multiple polymers (ethyl cellulose, cellulose acetate phthalate, and hydroxypropyl methyl cellulose acetate succinate) in a layered coating system. This composite approach creates a coating that resists alcohol-induced dose dumping while maintaining controlled release under normal conditions, resolving the contradiction between reliable drug release control and resistance to alcohol effects.
Solution Approach 2:
The patent implements local quality by creating different coating layers with specific functions: an inner layer for controlled release and an outer layer for alcohol resistance. Each layer has tailored polymer composition and thickness to address specific requirements, allowing the coating to exhibit different properties in different regions to simultaneously achieve controlled release and alcohol resistance.
2Object-affected harmful factors
If a polymer coating is applied to prevent dose dumping, then alcohol resistance is improved, but drug release may be delayed or prevented under normal conditions
Solution Approach 1:
The patent applies dynamics by designing a coating system that dynamically responds to environmental conditions. The coating allows drug release under normal gastrointestinal conditions while dynamically resisting alcohol-induced premature release. The polymer composition and layer structure enable the coating to adapt its permeability based on the presence or absence of alcohol, maintaining appropriate drug release timing.
Solution Approach 2:
The patent implements parameter changes by selecting polymers with specific dissolution characteristics and combining them in controlled ratios. The coating parameters (polymer type, thickness, composition ratio) are optimized to ensure drug release occurs at the appropriate time under normal conditions while changing the coating's resistance parameters when alcohol is present.
3Reliability
If multiple release-rate-controlling mechanisms are used in modified release formulations, then drug release control is enhanced, but the formulation becomes more complex and vulnerable to alcohol-induced dose dumping
Solution Approach 1:
The patent applies segmentation by dividing the coating into distinct layers, each with a specific polymer composition and function. This segmented approach simplifies the overall formulation design by assigning specific roles to each layer (inner layer for controlled release, outer layer for alcohol resistance), making the complex multi-mechanism system more manageable and less vulnerable to alcohol-induced dose dumping.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer-coated formulations ensure consistent drug release without significant acceleration in the presence of alcohol, providing modified release profiles that prevent dose dumping and maintain therapeutic efficacy.
Implementation Method 1
oral formulation with increased resistance to alcohol-mediated dissolution
Data Source
AI summary
The invention relates to modified release oral formulations of therapeutic agents, including gamma hydroxybutyrate (GHB), paracetamol, codeine or oxycodone, which are resistant to alcohol induced dose dumping. Provided are formulations that have improved resistance to rapid release of the active ingredient in the presence of increasing amounts of alcohol. Also provided are formulations that can reduce or prevent the release of the active ingredient following exposure to alcohol-containing media. The invention also relates to methods of making the formulations, and methods of their use for the treatment of sleep disorders such as apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus.


